About this episode

The episode discusses recent findings in the treatment of bacteremia and heart failure, including the use of cefazolin and midodrine.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia * Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis The Impact of Midodrine on Guideline-Directed Medical Therapy in Patients Admitted With Systolic Heart Failure This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Topics covered

• bacteremia treatment
• randomized trials
• systematic review
• meta-regression analysis
• heart failure therapy

Keywords

• Cefazolin
• bacteremia
• Staphylococcus aureus
• Midodrine
• heart failure
• randomized trials
• systematic review

Mentioned in this episode

Organizations: Cefazolin, Methicillin-Susceptible Staphylococcus aureus, Midodrine, Guideline-Directed Medical Therapy, Systolic Heart Failure, Sensible Medicine

More episodes of Sensible Medicine

• This Fortnight in Medicine XXX · July 15, 2026 · 45 min
• Friday Reflection 62: The Ethics of Telling Patients We Have Nothing Left to Offer · June 26, 2026 · 5 min
• This Fortnight in Medicine XXVIII · June 17, 2026 · 32 min

Explore listener stats, chart rankings, contacts and more on the Sensible Medicine podcast page.